Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: Implications for the biophysical role of highly unsaturated fatty acids

American Journal of Clinical Nutrition

Volumn 71, Issue 1 SUPPL., 2000, Pages

  Hibbeln, Joseph R ^a   Umhau, John C ^a   George, David T ^a   Shoaf, Susan E ^a   Linnoila, Markku ^a   Salem Jr , Norman ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHOLESTEROL; HOMOVANILLIC ACID; NEUROTRANSMITTER;

ADULT; ALCOHOLISM; CEREBROSPINAL FLUID; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; HUMAN; LIPID ANALYSIS; MALE; METABOLITE; PATHOGENESIS; REGRESSION ANALYSIS; SUICIDE; VIOLENCE;

EID: 0033958249     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.1.331s     Document Type: Conference Paper

References (72)

1. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-14.
2. Zureik M, Courbon D, Ducimetiere P. Serum cholesterol concentration and death from suicide in men: Paris prospective study. BMJ 1996;313:649-51.
3. Gallerani M, Manfredini R, Caracciolo S, Scapoli C, Molinari S, Fersini C. Serum cholesterol concentrations in parasuicide. BMJ 1995;310:1632-6.
4. Brown LS, Salive ME, Harris TB, Simonsick EM, Guralnik JM, Kohout FJ. Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ 1994;308:1328-32.
5. Harrison RWS, Ashton CH. Do cholesterol lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. BrJ Pharmacol 1994;37:231-6.
6. Cummings P, Psaty BM. The association between cholesterol and death. Ann Intern Med 1994;120:848-55.
7. Wardle J, Armitage J, Collins R, Wallendszus K, Keech A, Lawson A. Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. The Oxford Cholesterol Study Group. BMJ 1996;313:75-8.
8. Weidner G, Connor SL, Hollis JF, Connor WE. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. Ann Intern Med 1992;117:820-3.
9. Hamazaki T, Sawazaki S, Kobayashi M. The effect of docosahexaenoic acid on aggression in young adults. A double-blind study. J Clin Invest 1996;97:4:1129-34.
10. Endelberg H. Low cholesterol and suicide. Lancet 1992;339:727-9.
11. Stanley M, Träskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 1985;37:1279-86.
12. Linnoila VM, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid levels of 5-hydroxyindolacetic acid concentrations differentiate impulsive from non-impulsive violent behavior. Life Sci 1983;33:2609-14.
13. Roy A, Virkkunen M, Linnoila M. Serotonin in suicide, violence, and alcoholism. In: Coccaro E, Murphy P, eds. Serotonin in major psychiatric disorders. Washington, DC: American Psychiatric Association, 1991:187-208.
14. Virkkunen M, Rawlings R, Tokola R, et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994;51:20-7.
15. Mann JJ. Violence and aggression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, Ltd, 1995:1919-28.
16. Engström G, Alsen M, Regnell G, Träskman-Benz L. Serum lipids in suicide attempters. Suicide Life Threat Behav 1995;25:393-400.
17. Steegmans PHA, Fekkes D, Hoes AW, van der Does E, Grobbee DE. Low serum cholesterol concentration and serotonin metabolism in men. BMJ 1996;312;221.
18. Modai I, Valevski A, Kikinzon L, Jerushalmy Z, Weizman A. Lack of association between cholesterol blood levels and platelet serotonin uptake. Eur Psychiatry 1995;10:352-4.
19. Higley JD, Mehlman PT, Poland RE, et al. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 1996;40:1067-82.
20. Lerer B, Gillion D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B. Interrelationship of age, depression and central serotinergic function: evidence from fenfluramine challenge studies. Int Psychogeriatr 1996;8:83-102.
21. Ganziago JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subtractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-34.
22. Sabesin SM, Bertram PD, Freeman MR. Lipoprotein metabolism in liver disease. Adv Intern Med 1980;25:117-46.
23. LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 1994; 36:326-37.
24. LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings in animal studies. Biol Psychiatry 1994;36:395-421.
25. Buydens-Branchey L, Branchey MH, Noumair D. Age of onset of alcoholism. I. Relationship to psychopathology. Arch Gen Psychiatry 1989;46:225-30.
26. Roy A, Virkkunen M, Linnoila VM. Reduced serotonin turnover in a subgroup of alcoholics? Prog Neuropsychopharmacol Biol Psychiatry 1987;11:173-7.
27. Fils-Aime M, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila VM. Early-onset alcoholics have lower cerebrospinal fluid 5-HIAA than late-onset alcoholics. Arch Gen Psychiatry 1996;53:221-16.
28. Virkkunen M. Serum cholesterol levels in homicidal offenders: a low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology 1983;10:65-9.
29. Pawlosky RJ, Salem N Jr. Ethanol exposure causes a decrease in docosahexaenoic acid and an increase in docosapentaenoic acid in feline brains and retinas. Am J Clin Nutr 1995;61:1284-9.
30. Pawlosky RJ, Salem N Jr. Chronic alcohol exposure in rhesus monkeys alters electroretinograms and decreases levels of neural docosahexaenoic acid. Alcohol Clin Exp Res 1999;23:311-7.
31. Williams JB, Gibbon M, First MB, et al. The structured clinical interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-6.
32. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35:837-8.
33. Strogaad H, Neilsen SD, Gluud C. The validity of the Michigan alcohol screening test (MAST). Alcohol Alcohol 1994;29:493-502.
34. Buss AH, Durkee A. An inventory for different kinds of hostility. J Consult Psychol 1957;22:415-8.
35. Eckardt MJ, Parker ES, Noble EP, Feldman DJ, Gottsckalk LA. Relationship between neuropsychological performance and alcohol consumption in alcoholics. Biol Psychiatry 1978;13: 551-64.
36. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria, rationale and reliability. Arch Gen Psychiatry 1978;35:773-82.
37. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised. 3rd ed. Washington, DC: American Psychiatric Association, 1987.
38. Muscettola G, Wehr T. Goodwin FK. Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects. Am J Psychiatry 1977;134:914-6.
39. Scheinin M. Chang W, Kirk K, Linnoila VM. Simultaneous determination of 3-methoxy-4-hydroxyphenolglycol. 5-hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid with high performance liquid chromatography using electrochemical detection. Anal Biochem 1983;131:246-53.
40. Polinski RJ, Brown RT, Burns RS, Harvey-White J, Kopin IJ. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindolacetic acid in multiple system atrophy with autonomie failure. J Neurol Neurosurg Psychiatry 1988;51:914-9.
41. Hibbeln JR, Salem N Jr. Risks of cholesterol-lowering therapies. Biol Psychiatry 1996;40:686-7.
42. Agren H, Mefford IN, Rudorfer MV, Linnoila VM, Potter WZ. Interacting neurotransmitter systems: a nonexperimental approach to the 5-HIAA-HVA correlation in human CSF. Psychiatry Res 1986;20:175-93.
43. Kunugi H, Takei N, Aoki H, Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry 1997;1:196-200.
44. Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K. Low serum cholesterol level and attempted suicide. Am J Psychiatry 1995; 152:419-23.
45. Corrigan FM, Gray RF, Skinner ER, Strathdee A, Horrobin D. Plasma lipoproteins and apolipoproteins in individuals convicted of violent crimes. In: Hillbrand M, Spitz, RT, eds. Lipids, health and human behavior. Washington. DC: American Psychological Association Press, 1997:167-78.
46. Virkkunen ME, Horrobin DF, Jenkins DK, Manku MS. Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent and impulsive offenders. Biol Psychiatry 1987; 22:1087-96.
47. Keys A, Anderson J, Grande F. Serum cholesterol changes in response to diet. IV. Particular saturated fatty acids in the diet. Metabolism 1965;14:776-86.
48. Dobbing J. The entry of cholesterol into rat brain during development. J Neurochem 1963;10:739-42.
49. Pardridge WM, Mietus LJ. Palmitate and cholesterol transport through the blood brain barrier. J Neurochem 1980;34; 463-6.
50. Edmond J, Korsak RA, Morro JW, Torok-Both G, Catlin DH. Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J Nutr 1991;121:1323-30.
51. 14C] glucose into 15-day old rats. J Neurochem 1975;24:117-21.
52. Jones JP, Nicholas HJ, Ramsay RB. Rate of sterol formation by rat brain glia and neurons in vitro and in vivo. J Neurochem 1975; 24:122-6.
53. Salem N Jr. Omega-3 fatty acids: molecular and biochemical aspects. In: Spiller GA, Scala J, eds. New roles for selective nutrients. New York: Alan R Liss Inc. 1989:109-228.
54. Connor WE, Neuringer M, Lin DS. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes and plasma of rhesus monkeys. J Lipid Res 1990;31:237-47.
55. Salem N Jr., Kim HY, Yergey JA. Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A, Kifer RR, Martin R, eds. Health effects of polyunsaturated fatty acids in seafoods. New York: Academic Press, 1986;15:263-317.
56. Miczek KA, Weerts EM, DeBold JF. Alcohol aggression and violence: biobehavioral determinants. In: Martin SE, ed. Alcohol and interpersonal violence: fostering multidisciplinary perspectives. Rockville, MD: National Institutes of Health, 1993:83-119. (NIAAA research monograph no. 24.)
57. Heron DS, Shinitzky M, Hershkowitz M, Samuel D. Lipid fluidity modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci U S A 1980;77:7463-7.
58. Mitchell DC, Straume M, Litman BJ. Role of sn-2-polyunsaturated phospholipids and control of membrane receptor conformational equilibrium: effects of cholesterol and acyl chain unsaturation on the metarhodopsin I-metarhodopsin II equilibrium. Biochemistry 1992;31:662-70.
59. Huster D, Arnold K, Garwrish K. Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry 1998;37:17299-308.
60. Mitchell DC, Litman B. Effect of cholesterol on membrane order and dynamics in highly polyunsaturated phospholipid bilayers. Biophys J 1998;75:896-908.
61. Litman BJ, Lewis EN, Levin IW. Packing characteristics of highly unsaturated bilayer lipids: Raman spectroscopic studies of multilamellar phosphatidylcholine dispersions. Biochemistry 1991;30:2:313-9.
62. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996;31:S193-7.
63. Niebylski CD, Salem N Jr. A calorimetric investigation of a series of mixed-chain polyunsaturated phosphatidylcholines: effect of sn-2 chain length and degree of unsaturation. Biophys J 1994; 67:6:2387-93.
64. Salem N Jr, Niebylski CD. The nervous system has an absolute molecular species requirement for proper function. Mol Membr Biol 1995;12:1:131-4.
65. Kaplan JR, Shively CA, Fontenot MB, et al. Demonstration of an association among dietary cholesterol, central serotinergic activity, and social behavior in monkeys. Psychosom Med 1994;56:479-84.
66. Fernstrom MH, Verrico CD, Ebaugh A, Fernstrom JD. Diet-related changes in serum cholesterol concentrations do not alter tryptophan hydroxylase rate or serotonin concentrations in gerbil brain. Life Sci 1996;58:1433-44.
67. DeLion S, Chalon S, Herault J, Guilloteau D, Besnard J, Durand G. Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats. J Nutr 1994;124:2466-76.
68. Stanley M, Mann JJ. Increased serotonin-2 binding in frontal cortex of suicide victims. Lancet 1983;1:214-6.
69. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995;62:1-9.
70. Hibbeln JR, Umhau JC, George DT, Salem N Jr. Do plasma polyunsaturates predict hostility and depression? World Rev Nutr Diet 1997;82:175-86.
71. Owens SP, Innis S. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotinergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula fed piglets. J Nutr 1999;129:2088-93.
72. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-12.